Donor organizations poured millions of dollars into U.S. firm Cepheid’s diagnostic equipment to tackle disease in poor countries. When COVID-19 struck, the system fell apart.
Related topics
Topic | Replies | Views | Activity | |
---|---|---|---|---|
Diagnostics company Cepheid overcharging and undersupplying critical COVID-19 test | 0 | 573 | July 28, 2020 | |
Friday 26 Nov: MSF webinar on diagnostics manufacturing in Africa | 0 | 513 | November 23, 2021 | |
Substantial Public Investments in GeneXpert Underscore Need for Affordable Pricing | 0 | 346 | September 2, 2021 | |
Countries rush to build diagnostic capacity as coronavirus spreads | 0 | 337 | February 11, 2020 | |
Global Fund, Stop TB Partnership and USAID Announce New Collaboration with Danaher to Reduce Price and Increase Access to Cepheid’s TB Test | 0 | 421 | September 20, 2023 |